Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Abuse liability of flunitrazepam

J H Woods1, G Winger

  • 1Department of Pharmacology, University of Michigan Medical School, Ann Arbor 48109-0632, USA.

Journal of Clinical Psychopharmacology
|June 1, 1997
PubMed
Summary

Flunitrazepam, a potent hypnotic, shows similar abuse potential and dependence liability to other benzodiazepines in experimental studies. Its distinct preference among opioid abusers is noted, but it poses no unique public health threats.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A thermostable bacterial cocaine esterase rapidly eliminates cocaine from brain in nonhuman primates.

Translational psychiatry·2014
Same author

Reply from e-d. Schulze.

Trends in ecology & evolution·2011
Same author

Interaction of 5-HT2A and 5-HT2C receptors in R(-)-2,5-dimethoxy-4-iodoamphetamine-elicited head twitch behavior in mice.

The Journal of pharmacology and experimental therapeutics·2010
Same author

14 beta-O-cinnamoylnaltrexone and related dihydrocodeinones are mu opioid receptor partial agonists with predominant antagonist activity.

Journal of medicinal chemistry·2009
Same author

A comparison of the physiological, behavioral, neurochemical and microglial effects of methamphetamine and 3,4-methylenedioxymethamphetamine in the mouse.

Neuroscience·2007
Same author

Relative reinforcing effects of cocaine, remifentanil, and their combination in rhesus monkeys.

The Journal of pharmacology and experimental therapeutics·2006

Area of Science:

  • Pharmacology
  • Addiction Medicine
  • Public Health

Background:

  • Flunitrazepam is a widely prescribed hypnotic, but its illicit use and association with
  • date rape
  • have raised concerns.
  • Concerns exist regarding flunitrazepam's potential for greater abuse liability compared to other benzodiazepines.
  • Opioid abusers report a distinct preference for flunitrazepam over other benzodiazepines.

Purpose of the Study:

  • To compare the pharmacological properties and abuse potential of flunitrazepam with other benzodiazepines.
  • To evaluate the public health risks associated with flunitrazepam abuse.

Main Methods:

  • Review of experimental studies on animals and human subjects.
  • Analysis of survey data from typical patient populations and opioid abusers.
  • Assessment of medical emergency data and overdose toxicity.

Main Results:

  • Flunitrazepam is pharmacologically similar to other benzodiazepines, with high potency and efficacy.
  • No significant differences were found in drug-taking behavior, dependence liability, or withdrawal characteristics.
  • Flunitrazepam abuse among opioid users appears to be the only distinguishing factor, without unique public health threats.

Conclusions:

  • Flunitrazepam exhibits similar abuse potential and dependence liability to other benzodiazepines.
  • The preference for flunitrazepam among opioid abusers is not fully explained by pharmacological differences.
  • Current evidence does not indicate unique public health risks associated with flunitrazepam abuse.

Related Experiment Videos